Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990. National Nosocomial Infections Surveillance System
- PMID: 8486965
- DOI: 10.1093/infdis/167.5.1247
Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990. National Nosocomial Infections Surveillance System
Abstract
To identify pathogens causing nosocomial fungal infections and the secular trend in their incidence in US hospitals, data from the National Nosocomial Infections Surveillance System, 1980-1990, were analyzed. During that period, 30,477 fungal infections were reported. The rate rose from 2.0 to 3.8 infections/1000 discharges. The highest number of nosocomial fungal infections/1000 discharges was reported from the burn/trauma service (16.1). Candida albicans was the most frequently isolated fungal pathogen (59.7%), followed by other Candida species (18.6%). The rate increased at all four major anatomic sites of infection. Patients with bloodstream infections who had a central intravascular catheter were more likely to have a fungal pathogen isolated than were other patients with bloodstream infection (relative risk = 3.2; P < .001): 29% of fungemia patients and 17% of patients with bloodstream infection due to other pathogens died during hospitalization (P < .001). Fungi are emerging as important nosocomial pathogens and control efforts should target fungal infections, especially fungemia.
Similar articles
-
Secular trends in the epidemiology of nosocomial fungal infections at a teaching hospital in Taiwan, 1981 to 1993.Infect Control Hosp Epidemiol. 1997 May;18(5):369-75. doi: 10.1086/647628. Infect Control Hosp Epidemiol. 1997. PMID: 9154483
-
Nosocomial infections in medical intensive care units in the United States. National Nosocomial Infections Surveillance System.Crit Care Med. 1999 May;27(5):887-92. doi: 10.1097/00003246-199905000-00020. Crit Care Med. 1999. PMID: 10362409
-
Nosocomial infections in coronary care units in the United States. National Nosocomial Infections Surveillance System.Am J Cardiol. 1998 Sep 15;82(6):789-93. doi: 10.1016/s0002-9149(98)00450-0. Am J Cardiol. 1998. PMID: 9761092
-
Epidemiology of nosocomial fungal infections, with emphasis on Candida species.Clin Infect Dis. 1995 Jun;20(6):1526-30. doi: 10.1093/clinids/20.6.1526. Clin Infect Dis. 1995. PMID: 7548503 Review.
-
Nosocomial Fungal Infections: Epidemiology, Infection Control, and Prevention.Infect Dis Clin North Am. 2021 Dec;35(4):1027-1053. doi: 10.1016/j.idc.2021.08.002. Infect Dis Clin North Am. 2021. PMID: 34752219 Review.
Cited by
-
Successful management of chronic disseminated candidiasis in hematologic patients treated with high-dose liposomal amphotericin B: a retrospective study of the SEIFEM registry.Support Care Cancer. 2016 Sep;24(9):3839-45. doi: 10.1007/s00520-016-3208-0. Epub 2016 Apr 14. Support Care Cancer. 2016. PMID: 27075673 Free PMC article.
-
Candida biofilms: an update.Eukaryot Cell. 2005 Apr;4(4):633-8. doi: 10.1128/EC.4.4.633-638.2005. Eukaryot Cell. 2005. PMID: 15821123 Free PMC article. Review. No abstract available.
-
A non-polyene antifungal antibiotic from Streptomyces albidoflavus PU 23.J Biosci. 2005 Mar;30(2):201-11. doi: 10.1007/BF02703700. J Biosci. 2005. PMID: 15886456
-
Epidemiology of candidemia in Brazil: a nationwide sentinel surveillance of candidemia in eleven medical centers.J Clin Microbiol. 2006 Aug;44(8):2816-23. doi: 10.1128/JCM.00773-06. J Clin Microbiol. 2006. PMID: 16891497 Free PMC article.
-
Preliminary evaluation of a semisolid agar antifungal susceptibility test for yeasts and molds.J Clin Microbiol. 2000 Feb;38(2):537-41. doi: 10.1128/JCM.38.2.537-541.2000. J Clin Microbiol. 2000. PMID: 10655341 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical